MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-29-2026
MiMedx Group Total Assets 2011-2026 | MDXG
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets MiMedx Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 343 M | 264 M | 239 M | 171 M | 188 M | 202 M | 167 M | 123 M | 121 M | 193 M | 136 M | 109 M | 84.7 M | 35.2 M | 27.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 343 M | 27.1 M | 160 M |
Quarterly Total Assets MiMedx Group
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 309 M | 343 M | 291 M | 270 M | 264 M | 244 M | 230 M | 222 M | 239 M | 189 M | 176 M | 168 M | 171 M | 173 M | - | 174 M | 188 M | 181 M | 187 M | 191 M | 202 M | 202 M | 202 M | 202 M | 167 M | 167 M | 167 M | 167 M | 123 M | - | 123 M | 123 M | 121 M | 179 M | 200 M | 188 M | 117 M | 193 M | 193 M | 193 M | 136 M | 136 M | 136 M | 136 M | 109 M | 109 M | 109 M | 109 M | 84.7 M | 84.7 M | 84.7 M | 84.7 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 343 M | 27.1 M | 155 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 13.17 | 0.42 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.75 | 3.56 % | $ 385 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 25.75 | 0.16 % | $ 218 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.11 | 3.19 % | $ 1.28 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
77.2 M | $ 3.48 | 4.82 % | $ 130 M |  France |
 |
Inspire Medical Systems
INSP
|
907 M | $ 57.07 | 1.66 % | $ 1.68 B | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 61.31 | 2.01 % | $ 3.34 B |  Britain |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.47 | 2.59 % | $ 325 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.62 | 2.05 % | $ 38.6 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.27 | 1.39 % | $ 358 M | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.48 | 19.23 % | $ 6.88 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 5.4 | 12.63 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
47.8 B | $ 299.52 | -4.95 % | $ 114 B | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 92.15 | 2.18 % | $ 12.5 B | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 99.41 | -1.37 % | $ 3.38 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 19.28 | -1.25 % | $ 1.31 B | USA |
 |
NanoVibronix
NAOV
|
41.1 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.88 | 0.6 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 83.86 | -5.25 % | $ 2.91 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 84.39 | 1.07 % | $ 49.4 B | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.73 | 9.56 % | $ 68.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.37 | 6.64 % | $ 55.7 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.91 | 5.28 % | $ 38.1 M | USA |